Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/REDHILL-BIOPHARMA-LTD-12243230/news/RedHill-und-Kukbo-unterzeichnen-Lizenzvereinbarung-fur-oral-verabreichtes-Opaganib-zur-Behandlung-v-39766427/?utm_source=whatsapp&utm_medium=social&utm_campaign=share